Tilak Healthcare

Tilak Healthcare

Private
ParisHealthcare & Life Scienceshttps://tilakhealthcare.com

Last Round

Series B

Oct 12, 2023

Total Funding Raised

$21.42M

Momentum Score

25 /100

Company Overview

Tilak Healthcare is a digital health company that develops a platform of mobile medical games designed for the remote monitoring of patients with chronic diseases.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Medical Devices, Patient Engagement, Gaming, Clinical Trials

Business Model

B2B2C

Customer Profile

Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

digital therapeuticsDTxremote vision monitoringprescription digital therapeuticsPDTremote patient monitoringRPMmedical gamingophthalmologysoftware as a medical deviceSaMDtelemedicinepatient engagementchronic eye diseasetelemedicine reimbursementDigitale GesundheitsanwendungenDiGA

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tilak Healthcare Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Tilak Healthcare Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BOct 12, 2023
Series AOct 28, 2021
SeedMar 28, 2017

Key People

Founding team and executive leadership

Edouard Gasser

Co-Founder And CEO

Founding Team

Benoit GUEUGNON

Chief Financial Officer - Tilak Healthcare

Executive Team

Philip Bouchet

Chief Operating Officer Chief Product Technology Officer

Executive Team

Tilak Healthcare Investors

Notable investors and investment history

InvestorRounds
Matmut InnovationSeries A
iBionext Growth FundSeed, Series A
SWEN Capital PartnersSeries A, Series B
iBionextSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 18, 2026

    OdySight product now enables reimbursed telemonitoring in ophthalmology in France.

Tilak Healthcare Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tilak Healthcare Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tilak Healthcare's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range59
Year Founded2016
Last FundingOct 12, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.